JP2019520340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520340A5 JP2019520340A5 JP2018562993A JP2018562993A JP2019520340A5 JP 2019520340 A5 JP2019520340 A5 JP 2019520340A5 JP 2018562993 A JP2018562993 A JP 2018562993A JP 2018562993 A JP2018562993 A JP 2018562993A JP 2019520340 A5 JP2019520340 A5 JP 2019520340A5
- Authority
- JP
- Japan
- Prior art keywords
- faecalibacterium
- pharmaceutical composition
- microbial preparation
- purified
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344053P | 2016-06-01 | 2016-06-01 | |
| US62/344,053 | 2016-06-01 | ||
| PCT/US2017/035449 WO2017210428A1 (en) | 2016-06-01 | 2017-06-01 | Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520340A JP2019520340A (ja) | 2019-07-18 |
| JP2019520340A5 true JP2019520340A5 (enExample) | 2020-08-13 |
Family
ID=60479147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562993A Pending JP2019520340A (ja) | 2016-06-01 | 2017-06-01 | 炎症性腸疾患（ｉｂｄ）および他の障害を治療するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20170348360A1 (enExample) |
| EP (1) | EP3462882A4 (enExample) |
| JP (1) | JP2019520340A (enExample) |
| CN (1) | CN109803534A (enExample) |
| AU (1) | AU2017274416C1 (enExample) |
| CA (1) | CA3026414A1 (enExample) |
| WO (1) | WO2017210428A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ776366A (en) | 2015-05-22 | 2023-02-24 | Univ Minnesota | Methods for treating autism spectrum disorder and associated symptoms |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
| EP3606325B1 (en) | 2017-04-03 | 2024-09-04 | Gusto Global, LLC | Rational design of microbial-based biotherapeutics |
| US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| CA3058818A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| CA3064773A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| WO2018230695A1 (ja) * | 2017-06-16 | 2018-12-20 | ビオフェルミン製薬株式会社 | 脂肪関連疾患及び／又は炎症の予防又は治療剤 |
| WO2018236979A1 (en) * | 2017-06-20 | 2018-12-27 | Cornell University | Probiotic compositions and methods |
| CA3072032A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
| CA3084954A1 (en) | 2017-12-05 | 2019-06-13 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| CN111479579A (zh) * | 2017-12-12 | 2020-07-31 | 森永乳业株式会社 | 以双歧杆菌属细菌作为有效成分的组合物 |
| TWI813620B (zh) * | 2018-02-02 | 2023-09-01 | 香港中文大學 | 糞便微生物群移植的糞便真菌微生物和治療功效 |
| WO2019157566A1 (en) * | 2018-02-16 | 2019-08-22 | St Vincent's Hospital (Melbourne) Limited | Compositions and methods for promoting gut health |
| CA3096528A1 (en) * | 2018-04-13 | 2019-10-17 | Med-Life Discoveries Lp | Long chain dicarboxylic fatty acid (lcdfa) producing microbes and uses thereof |
| CN110396538B (zh) * | 2018-04-24 | 2023-05-23 | 深圳华大生命科学研究院 | 偏头痛生物标志物及其用途 |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| US12144834B2 (en) * | 2018-09-13 | 2024-11-19 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| CA3114423A1 (en) | 2018-09-27 | 2020-04-02 | Finch Therapeutics Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
| WO2020227420A1 (en) * | 2019-05-06 | 2020-11-12 | The General Hospital Corporation | Monitoring and altering the gut microbiome in disease |
| AU2020310947A1 (en) * | 2019-07-11 | 2021-12-23 | Thomas Julius Borody | Method for gut mucosa preparation to enhance microbial engraftment |
| CA3147629A1 (en) | 2019-07-19 | 2021-01-28 | Finch Therapeutics Holdings Llc. | Methods and products for treatment of gastrointestinal disorders |
| CN110541026A (zh) * | 2019-08-17 | 2019-12-06 | 昆明医科大学第一附属医院 | 一种检测溃疡性结肠炎的生物标志物及应用 |
| AU2020365134A1 (en) * | 2019-10-18 | 2022-06-02 | Thaena Inc. | Fecal-derived sterile postbiotic composition and method therefor |
| EP3838276A1 (en) * | 2019-12-17 | 2021-06-23 | Exeliom Biosciences | Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation |
| EP3839072A1 (en) * | 2019-12-17 | 2021-06-23 | Luxia Scientific | Bacterial combinations predictive of the activity of multiple sclerosis |
| US20220408780A1 (en) * | 2020-02-11 | 2022-12-29 | The E. Wolfson Medical Center | A method effective for treating ulcerative colitis |
| US20230087012A1 (en) * | 2020-02-14 | 2023-03-23 | Cornell University | Transferable microbiota for the treatment of ulcerative colitis |
| CN111304120B (zh) * | 2020-02-24 | 2021-07-23 | 浙江大学 | Blautia sp B2132菌在预防和/或治疗炎症性肠病中的应用 |
| EP3875098A1 (en) * | 2020-03-04 | 2021-09-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Use of coprococcus bacteria for the treatment of metabolic syndrome and inflammatory bowel diseases |
| US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
| WO2021199048A1 (en) * | 2020-04-01 | 2021-10-07 | The E. Wolfson Medical Center | Ulcerative colitis diet, formulae, products and methods thereof |
| US20230256033A1 (en) * | 2020-06-09 | 2023-08-17 | Flagship Pioneering Innovations Vi, Llc | Physiologically acceptable compositions containing microorganisms or microbial products |
| KR102169794B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도 |
| KR102169795B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도 |
| CA3186783A1 (en) * | 2020-07-30 | 2022-02-03 | John A. KALLASSY | Methods and compositions for treating metabolic conditions |
| CN111888381A (zh) * | 2020-09-18 | 2020-11-06 | 广西细微生物科技有限责任公司 | 一种肠道微生物移植工艺 |
| CN116615561A (zh) * | 2020-09-28 | 2023-08-18 | 希杰生物科技株式会社 | 用于诊断或治疗炎性疾病的包含微生物的组合物 |
| WO2022212510A1 (en) * | 2021-04-01 | 2022-10-06 | Medibeacon Inc. | Methods of monitoring mucosal healing |
| EP4082545A1 (en) * | 2021-04-27 | 2022-11-02 | Diotheris | Combination product and methods for preventing the emergence of antibiotic-resistant bacteria under antibiotic treatment |
| KR102337993B1 (ko) * | 2021-10-27 | 2021-12-14 | 주식회사 바이오뱅크힐링 | 클로스트리디움 렙텀 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
| CN113974159B (zh) * | 2021-11-02 | 2023-06-27 | 美益添生物医药(武汉)有限公司 | 齿叶乳香树树脂在制备促进肠道有益菌增殖的产品中的应用 |
| CN119183380A (zh) * | 2022-05-13 | 2024-12-24 | 国立大学法人东京大学 | 对炎症性肠病(ibd)进行治疗或诊断的方法和组合物 |
| CN115944655A (zh) * | 2023-02-14 | 2023-04-11 | 上海奇诺普森生物科技有限责任公司 | 一种肠菌组合物及其在防治自闭症中的应用 |
| CN119970806B (zh) * | 2025-02-25 | 2026-03-03 | 浙江大学 | 多毛假解黄酮菌在制备预防、治疗和/或改善溃疡性结肠炎的药物中的应用 |
| CN119709558B (zh) * | 2025-02-26 | 2025-05-30 | 昆明医科大学第一附属医院(云南省皮肤病医院) | 布劳特氏菌emf75-02b1b及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1510821A1 (en) * | 2003-08-27 | 2005-03-02 | Universiteit Utrecht Holding B.V. | Diagnosis and treatment of mycobacterial infections |
| KR102435108B1 (ko) * | 2010-08-04 | 2022-08-22 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치 |
| CN103561752B (zh) * | 2011-03-09 | 2016-04-20 | 明尼苏达大学评议会 | 用于移植结肠微生物群的组合物和方法 |
| US20140363397A1 (en) * | 2011-09-14 | 2014-12-11 | Queen's University At Kingston | Method for treatment of disorders of the gastrointestinal system |
| JP2015535280A (ja) * | 2012-11-01 | 2015-12-10 | レイクスユニフェルシテイト フローニンゲン | 胃腸管において有益な細菌を刺激する方法及び組成物 |
| US11185562B2 (en) * | 2013-02-04 | 2021-11-30 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| MX2015011700A (es) * | 2013-03-05 | 2016-07-20 | Univ Groningen | Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion. |
| US20150246081A1 (en) * | 2014-03-03 | 2015-09-03 | Shayne Kenneth Morris | Probiotics with methods for growth and use separately and in combination |
| US9783858B2 (en) * | 2014-04-02 | 2017-10-10 | Northwestern University | Altered microbiome of chronic pelvic pain |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
-
2017
- 2017-06-01 WO PCT/US2017/035449 patent/WO2017210428A1/en not_active Ceased
- 2017-06-01 JP JP2018562993A patent/JP2019520340A/ja active Pending
- 2017-06-01 US US15/611,338 patent/US20170348360A1/en not_active Abandoned
- 2017-06-01 AU AU2017274416A patent/AU2017274416C1/en active Active
- 2017-06-01 CN CN201780043664.8A patent/CN109803534A/zh active Pending
- 2017-06-01 CA CA3026414A patent/CA3026414A1/en not_active Abandoned
- 2017-06-01 EP EP17807481.1A patent/EP3462882A4/en not_active Withdrawn
-
2020
- 2020-12-28 US US17/135,544 patent/US20210106629A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ojetti et al. | The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial | |
| Bergogne-Berezin | Treatment and prevention of antibiotic associated diarrhea | |
| US20210106629A1 (en) | Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders | |
| AU2010339573B2 (en) | Compositions and method for treatment and prophylaxis of inflammatory bowel disease | |
| US20210030818A1 (en) | Compositions for use in balancing microbiome | |
| JP2019525944A5 (enExample) | ||
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| BRPI0517273B1 (pt) | composição contendo uma mistura de três bactérias probióticas, uso desta para a prevenção e/ou tratamento de infecções do trato respiratório superior e na regularização da funcionalidade intestinal do organismo acometido por essas patologias e kit contendo uma mistura de três bactérias probióticas | |
| CA3011977A1 (en) | Treatment for modulating gut microbiota | |
| US11433102B2 (en) | Compositions and methods for treating Parkinson's disease (PD) and related disorders | |
| US11801275B2 (en) | Compositions and methods for common colds | |
| US10960034B2 (en) | MRSA infection protective agent | |
| ITMI950378A1 (it) | Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono | |
| CN114585380A (zh) | 胃肠健康组合物 | |
| Schultz et al. | Escherichia coli Nissle 1917 | |
| WO2021097288A1 (en) | Compositions and methods for treating neurodegenerative diseases | |
| CN111491643B (zh) | 预防或治疗耐药感染的含益生菌和益生元的药物组合物 | |
| US20230404970A1 (en) | Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics | |
| CN111436612A (zh) | 一种体内酵素及其制备方法与在抑制新型病毒方面的应用 | |
| RU2614730C1 (ru) | Антибактериальное средство и способ лечения кишечного иерсиниоза, или псевдотуберкулеза, или эшерихиоза | |
| Telaku et al. | Impact of Lactobacillus Reuteri and Three Other Probiotics in Helicobacter Pylori Eradication. Open Access Maced J Med Sci. 2022 Oct 27; 10 (B): 2215-2219 | |
| FR3096891A1 (fr) | Composition pour la prevention de la cystite simple et/ou recidivante | |
| CN116490175A (zh) | 维生素直接递送以在暴露于抗生素后平衡肠道微生物 | |
| UA122203C2 (uk) | Схема лікування із застосуванням сполуки тіакуміцину | |
| JP2004189709A (ja) | 酪酸菌入りのガム |